Inventor · disambiguated record
Vinayagam Kannan
Also filed as: KANNAN VINAYAGAM
25 granted patents·25 pending applications·261 citations·filing 2015–2023
97Inventor score
Top patents by PatentIndex Score
50 records- 0198US9375478B1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2015·Granted Jun 28, 2016·24 cites·11 claims
- 0297US10624864B2Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2019·Granted Apr 21, 2020·8 cites·18 claims
- 0397US10010575B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Jul 3, 2018·8 cites·19 claims
- 0497US9981006B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted May 29, 2018·8 cites·19 claims
- 0597US9974827B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted May 22, 2018·8 cites·18 claims
- 0697US9968649B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted May 15, 2018·8 cites·17 claims
- 0797US9962422B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted May 8, 2018·8 cites·17 claims
- 0897US9925233B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Mar 27, 2018·8 cites·24 claims
- 0997US9919026B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Mar 20, 2018·9 cites·14 claims
- 1097US9750785B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Sep 5, 2017·16 cites·11 claims
- 1197US9744239B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2015·Granted Aug 29, 2017·17 cites·19 claims
- 1297US9744209B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Aug 29, 2017·15 cites·13 claims
- 1397US9687526B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2016·Granted Jun 27, 2017·16 cites·20 claims
- 1496US12280024B2Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2023·Granted Apr 22, 2025·1 cites·4 claims
- 1596US11135265B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2019·Granted Oct 5, 2021·4 cites·16 claims
- 1696US9993520B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Jun 12, 2018·6 cites·14 claims
- 1796US9925234B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Mar 27, 2018·6 cites·15 claims
- 1896US9119876B1Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2015·Granted Sep 1, 2015·48 cites·19 claims
- 1995US11207372B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2019·Granted Dec 28, 2021·3 cites·13 claims
- 2095US9937223B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2017·Granted Apr 10, 2018·6 cites·18 claims
- 2194US9295657B1Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2015·Granted Mar 29, 2016·22 cites·21 claims
- 2293US11337938B2Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2020·Granted May 24, 2022·2 cites·18 claims
- 2391US10130592B2Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2015·Granted Nov 20, 2018·10 cites·18 claims
- 2489US2024091176A1Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 2584US12440458B2Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
- 2681US2019201476A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
- 2778US2018333454A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 2878US2018325984A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 2978US2018333453A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3078US2018325987A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3178US2018325991A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3278US2018325985A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3378US2018325986A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3478US2018325982A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3578US2018325983A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3678US2018325990A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3778US2018325989A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3878US2018325988A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3977US2018133285A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4077US2018153955A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4176US2019105288A1Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4275US12186362B2Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2021·Granted Jan 7, 2025·0 cites·18 claims
- 4374US2023256048A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 4474US2018250245A1Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4573US2021077568A1Peptide congeners with polymer excipientsPAR PHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 4672US2020188474A1Peptide congeners with polymer excipientsPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4770US2017189352A1Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2017·Application pending·0 cites
- 4869US2018185438A1Vasopressin formulations for use in treatment of hypotensionPAR PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 4961US2024278247A1Adapter for clinical, medical and laboratory containersVERTICE PHARMA LLC·Filed 2022·Application pending·0 cites
- 5055US2017165206A1Epinephrine formulationsPAR PHARMACEUTICAL INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vinayagam Kannan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →